Pilot or pivotal ? [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2018-06-28 00:13 (2071 d 03:53 ago) – Posting: # 18982
Views: 12,253

Hi Ohlbe,

❝ But then, isn't this whole discussion on alpha correction purely hypothetical too ?


As I see it, it is a mild case of testing into compliance if we don't correct alpha:
If T1 and T2 are both borderline bad (like GMR=0.8) then we will have increased prob >5% type I error) of approving one of them, i.e. approving an unapprovable product.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,912 posts in 4,806 threads, 1,636 registered users;
32 visitors (0 registered, 32 guests [including 7 identified bots]).
Forum time: 03:06 CET (Europe/Vienna)

Exploratory analysis: The art of finding a Rembrandt
in a Jackson Pollock.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5